Description: NightHawk Biosciences is a fully integrated biopharmaceutical company focused on the development of new drugs from discovery through commercialization. The Company leverages its integrated ecosystem of subsidiaries to accelerate the creation and manufacture of novel therapies that arm the immune system, breaking through barriers that prolong traditional drug development. This empowers us to bring our ideas to life with efficient control, superior quality, and uncharacteristic agility.
Home Page: www.nighthawkbio.com
NHWK Technical Analysis
627 Davis Drive
Morrisville,
NC
27560
United States
Phone:
919 240 7133
Officers
| Name | Title |
|---|---|
| Mr. Jeffrey Alan Wolf J.D. | Founder, Chairman, CEO & Pres |
| Mr. William L. Ostrander | CFO & Sec. |
| Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. | Chief Medical Advisor and Member of Scientific & Clinical Advisory Board |
| Colonel George E. Peoples Jr., F.A.C.S., FACS, M.D. | Chief Medical Advisor |
| Dr. Anthony M. Manning Ph.D. | Chief Scientific Advisor |
| Dr. Paul W. Tebbey M.B.A., Ph.D. | Sr. VP of Product Devel. & Portfolio Strategy |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3099 |
| Price-to-Sales TTM: | 3.8216 |
| IPO Date: | 2013-07-24 |
| Fiscal Year End: | December |
| Full Time Employees: | 49 |